CMPS — COMPASS Pathways Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere
U.S. STOCKS ON THE MOVE-Bloom Energy, BlackRock, CoreWeave
Compass Pathways rises as it launches US training grants for psilocybin care
UK's Compass Pathways Q4 loss widens on warrant liability adjustment
Brief: Compass Pathways Announces Exercise Of $200 Million In Outstanding Warrants
Compass Pathways climbs premarket after $150 mln equity raise
Brief: Compass Pathways Announces Pricing Of $150 Million Public Offering
Compass Pathways extends rally after psychedelic depression treatment's late-stage study win
U.S. STOCKS ON THE MOVE-Ormat Technologies, Southwest Airlines, Jack Henry
Compass Pathways jumps as depression treatment study meets main goal
U.S. STOCKS ON THE MOVE-Ormat Technologies, Accenture, Kinsale Capital
U.S. STOCKS ON THE MOVE-Albemarle, Fiserv, ConocoPhillips
U.S. STOCKS ON THE MOVE-Norwegian Cruise Line, Paramount Skydance, Compass Pathways
Compass Pathways' depression treatment meets main goal in late‑stage study (updated)
Compass Pathways jumps as depression treatment study meets main goal
Brief: Compass Pathways Successfully Achieves Primary Endpoint In Second Phase 3 Trial Evaluating Comp360 Psilocybin
Compass Pathways' depression treatment meets main goal in late‑stage study
U.S. STOCKS ON THE MOVEx-IDEX Corp, Union Pacific, Qualcomm
Compass Pathways falls; fast-track review of depression drug blocked, reports say